[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363270-105":59,"doc-detail-363270-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prmt1-mediated-asymmetric-dimethylation-of-arginine-residue-602-in-ddx1-promotes-cholangiocarcinoma-progression","PRMT1-mediated asymmetric dimethylation of arginine residue 602 in DDX1 promotes cholangiocarcinoma progression","","Cholangiocarcinoma (CCA) remains a highly malignant biliary cancer with limited diagnostic and therapeutic molecular biomarkers. Cross-analysis of proteomics and ADMA modificationomics identified DDX1 overexpression and elevated R602 asymmetric dimethylation (ADMA) modifications in CCA. PRMT1 was determined as the methyltransferase and USP10 as the deubiquitinating enzyme. Mechanistically, PRMT1-driven DDX1 R602-ADMA promotes nuclear localization and a USP10-PRMT1-DDX1 positive feedback loop, accelerating progression. The PRMT1 inhibitor GSK715 suppresses CCA development in an in vivo model, supporting therapeutic targeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prmt1-mediated-asymmetric-dimethylation-of-arginine-residue-602-in-ddx1-promotes-cholangiocarcinoma-progression/363270/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prmt1-mediated-asymmetric-dimethylation-of-arginine-residue-602-in-ddx1-promotes-cholangiocarcinoma-progression/363270.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does PRMT1 play in CCA in this study?","Question",{"text":112,"@type":113},"PRMT1 is identified as the methyltransferase responsible for asymmetric dimethylation of DDX1 at residue R602, and this modification is enhanced under hypoxia.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does USP10 connect to the PRMT1-DDX1 pathway?",{"text":117,"@type":113},"USP10 deubiquitinates DDX1 in the context of the PRMT1-mediated R602-ADMA modification, supporting DDX1 nuclear localization and reinforcing a positive feedback loop.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports GSK715 as a therapeutic approach?",{"text":121,"@type":113},"In a hydrodynamic in situ CCA mouse model, the PRMT1-specific inhibitor GSK715 inhibits CCA development in a DDX1 R602-ADMA–dependent manner, indicating chemopreventive potential.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363270,1790705020,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","pISSN 2287-2728 eISSN 2287-285X  \nOriginal Article  \n[https://doi.org/10.3350/cmh.2025.1252](https://doi.org/10.3350/cmh.2025.1252)[ ](https://doi.org/10.3350/cmh.2025.1252)Clinical and Molecular Hepatology 2026;32:843-865  \nPRMT1-mediated asymmetric dimethylationofarginine residue 602 in DDX1 promotes cholangiocarcinoma progression  \n* * *  \nWenzheng Liu , Yangwei Liao , Yiyang Kuai , Xin Gao, Xingmin Yan, Jingjing Li, Junsheng Chen, Jukun Su, Jingcong Zhou, Yizhu Kong, Siqin Huang, Zhiwei Zhang, Feng Peng, Bing Wang, and Yongjun Chen  \nDivision of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, P. R.China  \nGraphical Abstract  \nStudy Highlights  \n• We identified PRMT1 as the methyltransferase for DDX1 R602 in CCA, whose modification is enhanced under hypoxia.  \n• The USP10-PRMT1-DDX1 feedback loop is formed via ADMA modification-mediated deubiquitination and nuclear translocation.  \n• GSK3368715 inhibits CCA progression in a DDX1 R602-ADMA–dependent manner, supporting its therapeutic potential.  \nCopyright © 2026 by Korean Association for the Study of the Liver  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/3.0/](http://creativecommons.org/licenses/by-nc/3.0/)) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nClinical and Molecular Hepatology Volume_32 Number_ 2 April 2026  \nBackground/Aims: Cholangiocarcinoma (CCA) is a primary malignant neoplasm with an extremely poor prognosis. While combined chemoradiotherapy has been demonstrated to delay CCA progression to a certain extent, the absence of specific molecular biomarkers or targets significantly hinders the diagnosis and treatment of CCA. Methods: Through cross-analysis of proteomics and ADMA modificationomics, we identified DDX1 overexpressed in CCA with elevated R602-ADMA modifications. HPLC-MS/MS identified PRMT1 as the methyltransferase and USP10 as the deubiquitinating enzyme for DDX1. Immunofluorescence and nuclear-cytoplasmic partitioning experiments confirmed DDX1’s nuclear localization. GO and KEGG analyses clarify the biological functions of DDX1 in response to hypoxia. RNA-seq transcriptomics analyzed key pathways influenced by DDX1. A hydrodynamic in situ CCA mouse model was established to validate the chemopreventive effects of the PRMT1-specific inhibitor GSK715 on CCA development.  \nResults: DDX1 promotes CCA progression both in vivo and in vitro and can be inhibited by GSK715 . Mechanistically, PRMT1 mediates ADMA modification at position R602 of DDX1 . This modification promotes DDX1 nuclear localization by recruiting USP10 to deubiquitinate DDX1, while simultaneously inhibiting PRMT1 degradation. DDX1 promotes the transcription of PRMT1 and USP10 by binding to the mRNA 3’UTR region, establishing a positive feedback regulatory pathway. This mechanism promotes the occurrence and development of CCA and can serve asa target for the inhibitor GSK715 to suppress CCA progression.  \nConclusions: Our study identified DDX1-R602-ADMA modification as a novel ADMA modification in CCA. It further confirmed its pivotal role in CCA progression. Targeting the USP10-PRMT1-DDX1 axis may represent a significant therapeutic approach for CCA. (Clin Mol Hepatol 2026;32:843-865)  \nKeywords: Cholangiocarcinoma; Arginine asymmetric dimethylation; Ubiquitination; PRMT1; DDX1  \nCorresponding author : Yongjun Chen  \nDivision of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei 430030, P. R. China Tel: +8602783665375, Fax: +86-027-83662640, [E-mail: Yjchen@tjh.tjmu.edu.cn](E-mail: Yjchen@tjh.tjmu.edu.cn)  \n[https://orcid.org/0000-0002-4389-5399](https://orcid.org/0000-0002-4389-5399)  \nBing Wang  \nDivision of Hep","cbCaiuCjuLxLLuEg","https://ap.wps.com/l/cbCaiuCjuLxLLuEg","pdf",17423535,24,"English","# Background/Aims\n# Methods\n# Results\n# Conclusions\n# Introduction\n## Study Highlights","[{\"question\":\"What role does PRMT1 play in CCA in this study?\",\"answer\":\"PRMT1 is identified as the methyltransferase responsible for asymmetric dimethylation of DDX1 at residue R602, and this modification is enhanced under hypoxia.\"},{\"question\":\"How does USP10 connect to the PRMT1-DDX1 pathway?\",\"answer\":\"USP10 deubiquitinates DDX1 in the context of the PRMT1-mediated R602-ADMA modification, supporting DDX1 nuclear localization and reinforcing a positive feedback loop.\"},{\"question\":\"What evidence supports GSK715 as a therapeutic approach?\",\"answer\":\"In a hydrodynamic in situ CCA mouse model, the PRMT1-specific inhibitor GSK715 inhibits CCA development in a DDX1 R602-ADMA–dependent manner, indicating chemopreventive potential.\"}]","PRMT1-mediated asymmetric dimethylation of arginine residue 602 in DDX1 promotes cholangiocarcinoma progression | PDF",1790150577,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fc868b23cb961db4d4f5e49e0cf2fec.webp",983,1318,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd830a581ff00dead012162c7e365ed2.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e24484b7af4ce8524341b4d1f99dc99d.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72d8357ee78348301f665c3e8c8ce8a9.webp",980,1306]